TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

Also called NCT07460960

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Phase 2
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Lomonosov Moscow State University Medical Research and Educational Center (from the registry)
Registry
  • NCT NCT07460960
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07460960. Randomized; no masking; primary purpose other. Start 2026-03-05 (actual); primary completion 2027-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men
Condition
Erectile Dysfunction Due to Arterial Disease
Condition
Atheroscleroses
Condition
Erectile Disfunction
Condition
Endothelial Dysfunction
Condition
Androgen Profile
Condition
Testosterone
Intervention (Drug)
Pitavastatin 1-4 mg daily
Intervention (Drug)
Rosuvastatin 20-40 mg daily
Lead sponsor
Lomonosov Moscow State University Medical Research and Educational Center (class: other)
Collaborator
Nizhpharm (class: other)

Record details

Record id
cardio:ct-nct07460960
Content hash
c8265dfd47fa7d11bdec3d17f818133c05612dfc474af9abf42cb7c34b016ae6